Mansbach Samuel Ross 4

What Happened
Samuel Ross Mansbach, General Counsel and Chief Compliance Officer of Establishment Labs Holdings, was granted two equity awards on Feb 16, 2026: 4,082 stock units and 7,131 derivative/option-type units. Both awards were granted at $0.00 (i.e., no cash paid). Total shares involved: 11,213. These are grants/awards (not open‑market purchases or sales).

Key Details

• Transaction date: 2026-02-16; Filing date (Form 4): 2026-03-06 (filing appears late relative to the transaction).
• Awards: 4,082 stock units (grant, $0.00) and 7,131 derivative/option units (grant, $0.00). Combined = 11,213 shares affected.
• Vesting: Both awards vest 25% on Feb 16, 2027 and 25% on each anniversary thereafter for three more years (four-year vesting schedule), contingent on continued service (per footnotes F1 and F2).
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Footnotes: F1 = award of stock units under the 2018 Equity Incentive Plan; F2 = option-type award with the same four-year, 25% annual vesting schedule.
• Timeliness: The Form 4 was filed ~18 days after the transaction date, which is later than the usual 2-business-day deadline for Form 4s; late filings do not change the substance of the grant but can draw regulatory or market attention.

Context
These grants are typical equity compensation for executives and are awarded at no purchase price, with vesting tied to continued employment. Because these are time‑based awards (not immediate sales or exercises), they do not represent an immediate market buy or sell signal. The derivative award should be understood as an option-like grant that becomes earned over time; nothing in this filing indicates any cashless exercise or immediate disposition.